JENNIFER COLEMAN: Open Payments
NPI 1275995367 · DONALDSONVILLE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,011 in 43 payments from 16 companies in 2025. Trend: 2023 $186 · 2024 $558 · 2025 $1,011
Food & beverage: $912Education: $99
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 5 | $195 |
| Merck Sharp & Dohme LLC | 6 | $137 |
| Novartis Pharmaceuticals Corporation | 6 | $136 |
| Eisai Inc. | 4 | $82 |
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
| E.R. Squibb & Sons, L.L.C. | 3 | $55 |
| Ipsen Biopharmaceuticals, Inc | 2 | $55 |
| Lilly USA, LLC | 3 | $53 |
| Karyopharm Therapeutics Inc. | 2 | $44 |
| Pharmacosmos Therapeutics Inc. | 2 | $44 |
Products named: Enhertu, KEYTRUDA, Lenvima, DATROWAY, KISQALI, Somatuline Depot, VERZENIO, SCEMBLIX.
Industry payments across LA — which companies pay providers there.
